HUTCHMED (China) (HMDCF) Net Margin (QoQ) (2018 - 2021)
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Net Margin (QoQ) (2018 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.51 Bn | 197.52 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.48 Bn | 178.30 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.45 Bn | 124.60 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn |
| 6 | Moderna | 54.72 Bn | 49.59 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.31 Bn | 30.31 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -48,755.00 |
| Sep 28, 2021 | 24,624.00 |
| Jun 30, 2021 | 2,983.00 |
| Jun 30, 2020 | -996.00 |
| Mar 31, 2020 | 12,246.00 |
| Dec 31, 2019 | -138.00 |
| Sep 30, 2019 | 12,937.00 |
| Jun 30, 2019 | -26,316.00 |
| Mar 31, 2019 | 2,280.00 |
| Dec 31, 2018 | 1,986.00 |
| Sep 30, 2018 | -11,892.00 |
| Jun 30, 2018 | 18,327.00 |